Trial intelligence / Profile preview

Effect of Liraglutide on Weight Reduction in Non-diabetic Obese Patients

IRCT20250209064693N1Phase 2Completed

Sponsor
Semnan University of Medical Sciences
Start
Apr 2025
Modality
Peptides
Countries
1
01

Overview

Phase 2 trial of liraglutide in obesity, sponsored by Semnan University of Medical Sciences. Started Apr 2025; status: completed.

02

Drugs

03

Conditions

obesity

Beyond the preview

Go deeper on IRCT20250209064693N1.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20250209064693N1.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call